Universal maternal screening for neonatal group B streptococcal disease.
Group B streptococcal infection is a leading cause of neonatal morbidity and mortality in the developed world. Data obtained in our region suggest that the incidence in the UK may be higher than previously reported, and together with the results of a pilot study indicate that preventive strategies based on maternal risk factors alone would prevent less than half the cases of neonatal disease.
Halliday
E
E
Foote
K
K
Dryden
M
M
Heard
M
M
Down
R
R
Ward
J
J
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D008403:Mass Screening / Q000379:methods*; D008431:Maternal-Fetal Exchange; D010865:Pilot Projects; D011247:Pregnancy; D012307:Risk Factors; D013290:Streptococcal Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control; D013292:Streptococcus agalactiae / Q000302:isolation & purification*; D006113:United Kingdom / Q000453:epidemiology
D000900:Anti-Bacterial Agents